We aimed to estimate the use of healthcare services and the direct medical costs accrued by patients with diabetes mellitus (DM) during the year of the first severe hypoglycaemia (SH) event, as well as during the years before and after the event year.
| INTRODUCTION
Hypoglycaemia is one of the commonest acute complications associated with intensification of glucose-lowering therapies, and it is often experienced by those treated with insulin. Given that insulin use accounts for one-fourth of all treatments for diabetes mellitus (DM), 1 the number of insulin-related DM complications is expected to rise further by 2045 with the growing number of DM patients. 2 Severe hypoglycaemia (SH), which is defined as any hypoglycaemia episode requiring emergency assistance from health service personnel, has been recorded for as high as one in nine patients per year 3 among individuals with type 1 and type 2 DM (T1DM and T2DM) who are undergoing treatment with insulin. The use of oral anti-diabetic drugs can also result in SH events. 4 Evidence from large prospective cohort studies revealed that SH is associated with an accelerated cognitive decline in the elderly, 5 an elevated risk of cardiovascular disease, [6] [7] [8] all-site cancer 9 and mortality, 6, 7, 9, 10 along with the requirement for emergency admissions and hospitalizations.
On a global scale, SH imposes a substantial economic burden on national healthcare services, driven by an increasing need for blood glucose monitoring, emergency services, hospitalization and additional visits to doctors and allied health professionals. 11 A number of costof-illness and cost-consequence studies have reported the direct medical costs incurred per severe hypoglycaemic episode across clinical characteristics in developed countries, including the USA, 12-14 the UK, 15, 16 Denmark, 17 the Netherlands, 18 Germany, 7 Spain 19, 20 and South Korea. 21 While the mean costs of an SH episode can be estimated, there is a scarcity of information to date concerning costs during the preceding and subsequent years. Population cohort data can be used to estimate direct medical costs during the year of first episode, and during the preceding and subsequent years. Use of population cohort data could also be helpful in quantifying the disease burden at a national level, enabling an estimate of direct medical costs in light of the determinants, such as the number of comorbid conditions and the presence of DM-related complications. 22, 23 This research extends our knowledge in the area of comparative effectiveness and cost-effectiveness analysis of glucose-lowering therapies, focusing on the reduction of hypoglycaemic episodes and their associated economic impacts.
The aim of the present study was to report the use of healthcare resources and estimate direct medical costs in Hong Kong among patients with DM during the event year, during the year preceding the first SH episode and during subsequent years. We examined the influence of socio-demographic factors, including gender and age, and clinical characteristics, such as drug treatment regimen, duration of DM, type of DM, glycaemic control, mortality, presence of DMrelated complications and presence of comorbidities, on the direct medical costs of a first SH episode, allowing for improved projections of healthcare expenses incurred by DM patients suffering from SH. 
| MATERIALS AND METHODS

| Study design and patient sampling
| Estimation of annual direct medical costs
The approach adopted for estimating direct medical costs was similar to that of previously published studies. 22, 23 Annual direct medical costs were estimated according to the frequency of use of healthcare services under the Hospital Authority during 1 year, multiplied by the unit cost of the corresponding types of healthcare services. by specifying a maximum tolerance of the propensity score distance between SH patients and control patients. 28 Propensity score matching was performed by "psmatch2" command on a one-to-one basis without replacement and a calliper criterium of 0.001 in STATA. 29 Descriptive statistics including mean, standard deviation (SD) and 95% confidence interval (CI) were used to present baseline demographics and clinical characteristics between the SH group and the matched control group. Differences in baseline characteristics between the two groups were assessed using independent t-test for continuous variables or Chi-square test for categorical variables. The balance of characteristics between the two groups after matching was also indicated by standardized mean difference.
Mean numbers of utilization of healthcare services during the event year, and the years before and after the event year were reported for each group. Independent t-test was used to determine the mean number of use of healthcare services between groups. Negative binomial regressions were performed to assess factors that were associated with annual healthcare utilization during the event year.
In order to compare direct medical costs before and after the index year, a similar approach was adopted to estimate the costs of the preceding and subsequent years. Mean annual direct medical costs in different subgroups were compared using independent t-test for two groups, or one-way analysis of variance for three or more groups. The association between annual direct medical costs during the event year and baseline covariates was further analysed by fitting a generalized linear model with gamma family and identity link.
All statistical analyses were performed using STATA version 13.0
(StataCorp LP, College Station, Texas). All significance tests were twotailed and P values <0.05 were taken to indicate statistical significance.
| RESULTS
A detailed flowchart of subject sampling and the distribution of propensity score matching between the SH group and the control group are available online (Figures S1 and S2, respectively).
A total of 14 796 patients with a documented diagnosis of SH were identified. Among these, 11 347 patients remained in the cohort after excluding those who experienced events near the beginning or end date of the observation period. These patients were matched in a one-to-one ratio with the same number of control patients who had not experienced an SH event. A total of 22 694 patients (11 347 patients each in the SH and matched control groups) were included in the analysis.
| Sample characteristics
Baseline characteristics of patients in the SH group and the control group are available online (Table S3) . Although there were significant differences between the SH group and the control group concerning a number of characteristics, most of the standardized mean differences in characteristics were less than 0.1, implying that a balance was achieved in most covariates between the two groups.
| Healthcare service utilization
The frequency of use of healthcare services for the SH and matched control groups from Year −2 to Year +3 is depicted in Figure 1 . The mean for GOPC visit in the SH group reached the highest in Year 2 (5.36) and fell monotonically year by year, becoming the lowest in Year +3 (3.58). A similar pattern was observed for GOPC visit in the control group. The mean for GOPC visit in the control group was greater than that in the SH group for all years except Year −1 (for Year −1, P = 0.517; for other years, all P < 0.001). There was an initial increase in the mean for SOPC visit in the SH group from Year −2 (2.31) to Year 0 (3.30), followed by a subsequent monotonic decrease.
The mean for number of visits was the lowest in Year +3 (2.25). On the other hand, the mean for A&E services in the SH group increased from 0.44 in Year −2 and reached a peak in the index/event year, Year 0 (1.89), with a subsequent decline. In general, the mean for A&E services was greater in the SH group than in the control group in all years (P < 0.001). The mean for utilization of allied health professional services was relatively low, with less than 0.3 in the SH group and less than 0.5 in the control group in all years. Similarly, the mean for overnight hospitalization in ICU, CCU and HDU in the SH group was fairly low, with less than 0.13, 0.05 and 0.006, respectively, in all years. The average night stay in a general ward troughed in Year −2 (3.04) and peaked in Year 0 (17.58). On the other hand, the average overnight stay in a general ward remained similar throughout, with a mean of approximately six nights. Overall, patients in the SH group had a far higher mean for overnight hospitalization than that for patients in the control group (17.75 vs 0.29; P < 0.001) in Year 0. As for healthcare services related to an SH event, patients were hospitalized overnight most often during the event year, staying in a general ward, followed by use of A&E services. In contrast, patients utilized A&E services the most from Year +1 to Year +3, followed by overnight hospitalization.
During the event year, nearly all patients (98.6%) in the SH group were admitted to hospital, unlike those in the control group in which very few (1.1%) were admitted. In summary, the healthcare services of outpatient visit and overnight hospitalization in a general ward, in particular, were utilized by most patients, whereas A&E services and allied health professional services were utilized the least. The factors associated with each healthcare service utilized within the event year
for SH patients are available online (Table S4a-S4e). 
| Costs
| Comparison of annual direct medical costs by time and covariates
Annual direct medical costs during the event year for each subgroup are presented in Table 1 . In our sample, males reported a significantly higher direct medical cost than females, with mean direct medical costs for a male of 12 287 US$ and those for a female of 11 305 US$ (P = 0.006). The minimum mean direct medical cost was 8329 US$ for patients below 55 years of age and up to 13 120 US$ for patients 75 years of age or above in the subgroup analysis by age group. Mean costs between age groups differed significantly (P < 0.001). Considering direct medical costs by duration of DM (P < 0.001), patients with DM for one up to 5 years were those for whom the cost was highest Table 2 .
Costs for male patients were 1043 US$ higher than those for female patients (P = 0.004). Costs for patients who suffered from DM for one year up to 5 years were 1697 US$ higher than those for patients who suffered from DM for less than one year (P = 0.038 
| DISCUSSION
This study used population-based retrospective cohort data to describe the pattern of health service utilization and associated direct medical costs for DM patients during the year of the first SH event, the preceding years and the subsequent years. The focus of the study was to estimate the economic impact and the increased use of healthcare services associated with the occurrence of an SH event. Healthcare utilization during the event year was higher than that during the preceding and subsequent years. Inpatient hospitalization costs were the main driver of medical expenditure across the years.
Our further analysis of healthcare service utilization found that patients with a history of DM-related complications and an increasing number of comorbidities were associated with greater hospitalization admission rates during the event year. Correspondingly, the increase in direct medical costs was associated with poor glycaemic control, 30 treatment intensification, 31 incidence of DM-related complications 23, 32 and all-cause mortality. 22 Annual direct medical costs grew by 95.3% from 2481 US$ during the 2 years preceding the SH event to 4846 US$ during the year immediately preceding the SH. Such excessive growth in annual direct medical costs might be additional valuable information for use in risk assessment models concerning the first occurrence of SH.
In contrast, utilization of healthcare services on the part of those who did not experience an SH event was lower, with no use of HDU or CCU services during hospitalization. The major driver of total direct medical costs for matched controls was outpatient visits, a small proportion of which were emergency visits, and the use of allied health professional services in particular. Direct medical costs for SH patients during the event year were approximately 10-fold higher than those for patients without the experience of an SH event, primarily attributed to the additional length of hospitalization and to emergency services.
Type of DM and insulin use are highly inter-dependent, and have been identified as important covariates for direct medical costs during the SH event year. Although differences in cost per SH episode between patients with T1DM and those with T2DM exist across countries, our results were consistent with some published data.
Using the Local Impact of Hypoglycaemia Tool for financial impact assessment, average direct medical costs for severe episodes in patients with T1DM was found to be higher than those for patients with T2DM in a Spanish population. 17, 33 The costs were similar to those for T2DM patients in Denmark, 17 but were less than those for T2DM patients in the UK. 16 Comparing patients who use or do not use metformin, direct medical costs during the SH event year for those using metformin were lower than those not using metformin. consumption were neither included in the ICD-9-CM diagnosis coding nor routinely recorded in the database. Finally, the current cost analysis and estimation of the use of public healthcare resources and the associated annual direct medical costs attributable to DM patients is from the perspective of the Hospital Authority, which is known to be the largest public healthcare provider in Hong Kong. Outpatient visits and hospitalization within the sector of private healthcare providers, as well as patients' out-of-pocket costs and the indirect costs measured by productivity loss, were not measurable in our retrospective cohort data.
In conslusion, SH is associated with excessive hospital admission rates and direct medical costs, predominately during the year of the first SH event and significantly during the year before, as compared to the matched control patients who did not experience an SH event.
The population-based cohort data highlighted that the increased rates of emergency services and hospitalizations during the year before the first event could potentially be regarded as the occurrence of an SH event.
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